<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:atom="http://www.w3.org/2005/Atom" version="2.0">
  <channel>
    <title>ADA</title>
    <link>https://www.biospace.com/american-diabetes-association-ada</link>
    <description>ADA</description>
    <language>en-US</language>
    <lastBuildDate>Mon, 08 Jun 2026 13:08:42 GMT</lastBuildDate>
    <atom:link href="https://www.biospace.com/american-diabetes-association-ada.rss" type="application/rss+xml" rel="self" />
    <item>
      <title>MitoRx Therapeutics presents promising preclinical data on MTRX31, a mitochondrial-targeted small molecule for metabolically unhealthy obesity, at the American Diabetes Association’s 2026 Scientific Sessions</title>
      <link>https://www.biospace.com/press-releases/mitorx-therapeutics-presents-promising-preclinical-data-on-mtrx31-a-mitochondrial-targeted-small-molecule-for-metabolically-unhealthy-obesity-at-the-american-diabetes-associations-2026-scientific-sessions</link>
      <description />
      <pubDate>Mon, 08 Jun 2026 13:08:42 GMT</pubDate>
      <guid>https://www.biospace.com/press-releases/mitorx-therapeutics-presents-promising-preclinical-data-on-mtrx31-a-mitochondrial-targeted-small-molecule-for-metabolically-unhealthy-obesity-at-the-american-diabetes-associations-2026-scientific-sessions</guid>
    </item>
    <item>
      <title>Ascletis Reinforces Its Differentiated Obesity Portfolio at American Diabetes Association (ADA) 2026 Scientific Sessions, Showcasing ASC30 Clinical Data and Exciting Preclinical Findings from ASC37 and ASC39</title>
      <link>https://www.biospace.com/press-releases/ascletis-reinforces-its-differentiated-obesity-portfolio-at-american-diabetes-association-ada-2026-scientific-sessions-showcasing-asc30-clinical-data-and-exciting-preclinical-findings-from-asc37-and-asc39</link>
      <description />
      <pubDate>Mon, 08 Jun 2026 06:01:07 GMT</pubDate>
      <guid>https://www.biospace.com/press-releases/ascletis-reinforces-its-differentiated-obesity-portfolio-at-american-diabetes-association-ada-2026-scientific-sessions-showcasing-asc30-clinical-data-and-exciting-preclinical-findings-from-asc37-and-asc39</guid>
    </item>
    <item>
      <title>AMGEN PRESENTS NEW DATA ACROSS ITS CARDIOMETABOLIC PORTFOLIO AT AMERICAN DIABETES ASSOCIATION 86TH SCIENTIFIC SESSIONS</title>
      <link>https://www.biospace.com/press-releases/amgen-presents-new-data-across-its-cardiometabolic-portfolio-at-american-diabetes-association-86th-scientific-sessions</link>
      <description />
      <pubDate>Mon, 08 Jun 2026 05:53:18 GMT</pubDate>
      <guid>https://www.biospace.com/press-releases/amgen-presents-new-data-across-its-cardiometabolic-portfolio-at-american-diabetes-association-86th-scientific-sessions</guid>
    </item>
    <item>
      <title>Antag Therapeutics presents positive Phase 1 results at the 2026 Scientific Sessions of the American Diabetes Association for AT7687, a first-in-class GIPR antagonist</title>
      <link>https://www.biospace.com/press-releases/antag-therapeutics-presents-positive-phase-1-results-at-the-2026-scientific-sessions-of-the-american-diabetes-association-for-at7687-a-first-in-class-gipr-antagonist</link>
      <description />
      <pubDate>Mon, 08 Jun 2026 05:44:31 GMT</pubDate>
      <guid>https://www.biospace.com/press-releases/antag-therapeutics-presents-positive-phase-1-results-at-the-2026-scientific-sessions-of-the-american-diabetes-association-for-at7687-a-first-in-class-gipr-antagonist</guid>
    </item>
    <item>
      <title>The American Diabetes Association Announces Winners of the Innovation Challenge</title>
      <link>https://www.biospace.com/press-releases/the-american-diabetes-association-announces-winners-of-the-innovation-challenge</link>
      <description />
      <pubDate>Mon, 08 Jun 2026 05:43:21 GMT</pubDate>
      <guid>https://www.biospace.com/press-releases/the-american-diabetes-association-announces-winners-of-the-innovation-challenge</guid>
    </item>
    <item>
      <title>Novo Nordisk to present new data on Wegovy® across a wide range of cardiometabolic conditions at the American Diabetes Association's 2026 Scientific Sessions</title>
      <link>https://www.biospace.com/press-releases/novo-nordisk-to-present-new-data-on-wegovy-across-a-wide-range-of-cardiometabolic-conditions-at-the-american-diabetes-associations-2026-scientific-sessions</link>
      <description />
      <pubDate>Mon, 08 Jun 2026 05:13:44 GMT</pubDate>
      <guid>https://www.biospace.com/press-releases/novo-nordisk-to-present-new-data-on-wegovy-across-a-wide-range-of-cardiometabolic-conditions-at-the-american-diabetes-associations-2026-scientific-sessions</guid>
    </item>
    <item>
      <title>OrsoBio to Present Preclinical and Clinical Data from its Mitochondrial Protonophore Portfolio at the American Diabetes Association’s 2026 Scientific Sessions</title>
      <link>https://www.biospace.com/press-releases/orsobio-to-present-preclinical-and-clinical-data-from-its-mitochondrial-protonophore-portfolio-at-the-american-diabetes-associations-2026-scientific-sessions</link>
      <description />
      <pubDate>Mon, 08 Jun 2026 03:57:51 GMT</pubDate>
      <guid>https://www.biospace.com/press-releases/orsobio-to-present-preclinical-and-clinical-data-from-its-mitochondrial-protonophore-portfolio-at-the-american-diabetes-associations-2026-scientific-sessions</guid>
    </item>
    <item>
      <title>Verdiva Bio Presents Preclinical Data on Investigational Obesity Drug Candidates at the American Diabetes Association 86th Scientific Sessions</title>
      <link>https://www.biospace.com/press-releases/verdiva-bio-presents-preclinical-data-on-investigational-obesity-drug-candidates-at-the-american-diabetes-association-86th-scientific-sessions</link>
      <description />
      <pubDate>Mon, 08 Jun 2026 03:56:37 GMT</pubDate>
      <guid>https://www.biospace.com/press-releases/verdiva-bio-presents-preclinical-data-on-investigational-obesity-drug-candidates-at-the-american-diabetes-association-86th-scientific-sessions</guid>
    </item>
    <item>
      <title>Biomea Fusion Presents New Clinical and Translational Data for Icovamenib at the American Diabetes Association (“ADA”) 86th Scientific Sessions and Announces Expansion of Ongoing Phase I BMF-650 Study</title>
      <link>https://www.biospace.com/press-releases/biomea-fusion-presents-new-clinical-and-translational-data-for-icovamenib-at-the-american-diabetes-association-ada-86th-scientific-sessions-and-announces-expansion-of-ongoing-phase-i-bmf-650-study</link>
      <description />
      <pubDate>Mon, 08 Jun 2026 03:49:49 GMT</pubDate>
      <guid>https://www.biospace.com/press-releases/biomea-fusion-presents-new-clinical-and-translational-data-for-icovamenib-at-the-american-diabetes-association-ada-86th-scientific-sessions-and-announces-expansion-of-ongoing-phase-i-bmf-650-study</guid>
    </item>
    <item>
      <title>New data from Phase 2 ZUPREME-1 trial at the American Diabetes Association 2026 Scientific Sessions further support potential of petrelintide to redefine the weight management experience for people living with overweight and obesity</title>
      <link>https://www.biospace.com/press-releases/new-data-from-phase-2-zupreme-1-trial-at-the-american-diabetes-association-2026-scientific-sessions-further-support-potential-of-petrelintide-to-redefine-the-weight-management-experience-for-people-living-with-overweight-and-obesity</link>
      <description />
      <pubDate>Mon, 08 Jun 2026 02:17:28 GMT</pubDate>
      <guid>https://www.biospace.com/press-releases/new-data-from-phase-2-zupreme-1-trial-at-the-american-diabetes-association-2026-scientific-sessions-further-support-potential-of-petrelintide-to-redefine-the-weight-management-experience-for-people-living-with-overweight-and-obesity</guid>
    </item>
    <item>
      <title>Eledon Announces Presentation of Updated Data from Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients with Type 1 Diabetes at American Diabetes Association (ADA) 2026 Scientific Sessions</title>
      <link>https://www.biospace.com/press-releases/eledon-announces-presentation-of-updated-data-from-investigator-initiated-islet-transplant-trial-of-tegoprubart-in-patients-with-type-1-diabetes-at-american-diabetes-association-ada-2026-scientific-sessions</link>
      <description />
      <pubDate>Fri, 05 Jun 2026 07:22:57 GMT</pubDate>
      <guid>https://www.biospace.com/press-releases/eledon-announces-presentation-of-updated-data-from-investigator-initiated-islet-transplant-trial-of-tegoprubart-in-patients-with-type-1-diabetes-at-american-diabetes-association-ada-2026-scientific-sessions</guid>
    </item>
    <item>
      <title>Insulet to Spotlight New Data and Innovations Demonstrating How Omnipod® Simplifies Diabetes Management and Delivers Strong Clinical Outcomes at the American Diabetes Association 86th Scientific Sessions</title>
      <link>https://www.biospace.com/press-releases/insulet-to-spotlight-new-data-and-innovations-demonstrating-how-omnipod-simplifies-diabetes-management-and-delivers-strong-clinical-outcomes-at-the-american-diabetes-association-86th-scientific-sessions</link>
      <description />
      <pubDate>Thu, 04 Jun 2026 12:47:06 GMT</pubDate>
      <guid>https://www.biospace.com/press-releases/insulet-to-spotlight-new-data-and-innovations-demonstrating-how-omnipod-simplifies-diabetes-management-and-delivers-strong-clinical-outcomes-at-the-american-diabetes-association-86th-scientific-sessions</guid>
    </item>
    <item>
      <title>Arch Biopartners Featured in American Diabetes Association Thought Leadership Series at the 2026 Scientific Sessions in New Orleans</title>
      <link>https://www.biospace.com/press-releases/arch-biopartners-featured-in-american-diabetes-association-thought-leadership-series-at-the-2026-scientific-sessions-in-new-orleans</link>
      <description />
      <pubDate>Thu, 04 Jun 2026 12:36:44 GMT</pubDate>
      <guid>https://www.biospace.com/press-releases/arch-biopartners-featured-in-american-diabetes-association-thought-leadership-series-at-the-2026-scientific-sessions-in-new-orleans</guid>
    </item>
    <item>
      <title>Cambrian Bio to Present Two Posters on ATX-304 at the American Diabetes Association 86th Scientific Sessions</title>
      <link>https://www.biospace.com/press-releases/cambrian-bio-to-present-two-posters-on-atx-304-at-the-american-diabetes-association-86th-scientific-sessions</link>
      <description />
      <pubDate>Thu, 04 Jun 2026 05:34:30 GMT</pubDate>
      <guid>https://www.biospace.com/press-releases/cambrian-bio-to-present-two-posters-on-atx-304-at-the-american-diabetes-association-86th-scientific-sessions</guid>
    </item>
    <item>
      <title>Lexicon to Present Data at the American Diabetes Association (ADA) 2026 Scientific Sessions</title>
      <link>https://www.biospace.com/press-releases/lexicon-to-present-data-at-the-american-diabetes-association-ada-2026-scientific-sessions</link>
      <description />
      <pubDate>Wed, 03 Jun 2026 14:13:13 GMT</pubDate>
      <guid>https://www.biospace.com/press-releases/lexicon-to-present-data-at-the-american-diabetes-association-ada-2026-scientific-sessions</guid>
    </item>
    <item>
      <title>Augustine Therapeutics to Present Late-Breaking Poster at the American Diabetes Association’s 86th Scientific Sessions</title>
      <link>https://www.biospace.com/press-releases/augustine-therapeutics-to-present-late-breaking-poster-at-the-american-diabetes-associations-86th-scientific-sessions</link>
      <description />
      <pubDate>Tue, 02 Jun 2026 12:24:34 GMT</pubDate>
      <guid>https://www.biospace.com/press-releases/augustine-therapeutics-to-present-late-breaking-poster-at-the-american-diabetes-associations-86th-scientific-sessions</guid>
    </item>
    <item>
      <title>Genentech to Present New Data Advancing Its Obesity Portfolio at the American Diabetes Association’s 2026 Scientific Sessions</title>
      <link>https://www.biospace.com/press-releases/genentech-to-present-new-data-advancing-its-obesity-portfolio-at-the-american-diabetes-associations-2026-scientific-sessions</link>
      <description />
      <pubDate>Mon, 01 Jun 2026 08:12:43 GMT</pubDate>
      <guid>https://www.biospace.com/press-releases/genentech-to-present-new-data-advancing-its-obesity-portfolio-at-the-american-diabetes-associations-2026-scientific-sessions</guid>
    </item>
    <item>
      <title>Roche to present new data advancing its obesity portfolio at the American Diabetes Association’s 2026 Scientific Sessions</title>
      <link>https://www.biospace.com/press-releases/roche-to-present-new-data-advancing-its-obesity-portfolio-at-the-american-diabetes-associations-2026-scientific-sessions</link>
      <description />
      <pubDate>Mon, 01 Jun 2026 08:08:08 GMT</pubDate>
      <guid>https://www.biospace.com/press-releases/roche-to-present-new-data-advancing-its-obesity-portfolio-at-the-american-diabetes-associations-2026-scientific-sessions</guid>
    </item>
    <item>
      <title>Sparrow Pharmaceuticals to Present Phase 2a Results for Clofutriben in Type 2 Diabetes at the 2026 American Diabetes Association (ADA) Scientific Session</title>
      <link>https://www.biospace.com/press-releases/sparrow-pharmaceuticals-to-present-phase-2a-results-for-clofutriben-in-type-2-diabetes-at-the-2026-american-diabetes-association-ada-scientific-session</link>
      <description />
      <pubDate>Fri, 29 May 2026 14:07:54 GMT</pubDate>
      <guid>https://www.biospace.com/press-releases/sparrow-pharmaceuticals-to-present-phase-2a-results-for-clofutriben-in-type-2-diabetes-at-the-2026-american-diabetes-association-ada-scientific-session</guid>
    </item>
    <item>
      <title>SAB BIO to Present Data on SAB-142 at The American Diabetes Association’s 2026 Scientific Sessions and FOCIS 2026 Annual Meeting</title>
      <link>https://www.biospace.com/press-releases/sab-bio-to-present-data-on-sab-142-at-the-american-diabetes-associations-2026-scientific-sessions-and-focis-2026-annual-meeting</link>
      <description />
      <pubDate>Fri, 29 May 2026 13:43:27 GMT</pubDate>
      <guid>https://www.biospace.com/press-releases/sab-bio-to-present-data-on-sab-142-at-the-american-diabetes-associations-2026-scientific-sessions-and-focis-2026-annual-meeting</guid>
    </item>
  </channel>
</rss>
